Startup based in France, most recent round Series-c-plus, 1 tracked investor.
Based in France, GenOway is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
GenOway develops and supplies genetically engineered laboratory animal models and related services for biomedical research and drug discovery, including custom genetically modified rodents and gene-editing solutions. It supports preclinical research by providing models, reagents and associated scientific services to pharmaceutical, biotech and academic customers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.